HEDRICK MARC H — SEC insider filings
SEC reporting owner CIK 1203672. 27 insider filings on record with FilingPulse; latest filed 2026-10-01.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2020-08-13 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 11 legs across 11 filings — 48,638 shares, $78,611 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 2,068 shares, $4,053 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: purchase of 12,255 shares @ $2.04 ($25,000) in CERENOME, INC., filed 2024-05-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CERENOME, INC. (CNSY) | Chief Executive Officer, Director | 27 | 11 legs · 48,638 sh · $78,611 | 1 leg · 2,068 sh · $4,053 | 35 |
Insider filings — HEDRICK MARC H
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-01 | 4 | CERENOME, INC. (CNSY) | Option exercise (M): 6,387 @ $0 · Option exercise (M): 8,066 @ $0 · Option exercise (M): 1,986 @ $0 · Option exercise (M): 6,387 (derivative) @ $0 · Option exercise (M): 8,066 (derivative) @ $0 · Option exercise (M): 1,986 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 6,387 @ $0 · Option exercise (M): 8,066 @ $0 · Option exercise (M): 1,986 @ $0 · Option exercise (M): 6,387 (derivative) @ $0 · Option exercise (M): 8,066 (derivative) @ $0 · Option exercise (M): 1,986 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 23,834 (derivative) @ $0 · Grant/award (A): 23,834 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 159,681 @ $0 · Option exercise (M): 201,632 @ $0 · Option exercise (M): 159,681 (derivative) @ $0 · Option exercise (M): 201,632 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 2,419,582 (derivative) @ $0 · Grant/award (A): 2,419,582 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 159,681 @ $0 · Option exercise (M): 159,681 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4/A | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 5,748,506 (derivative) @ $0 · Grant/award (A): 1,916,168 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 159,681 @ $0 · Option exercise (M): 159,681 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 5,748,506 (derivative) @ $0 · Grant/award (A): 1,916,168 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 400,489 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 197,595 (derivative) @ $0 | EDGAR |
| 2024-09-11 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 8,000 @ $1.23 | EDGAR |
| 2024-05-10 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 12,255 @ $2.04 · Grant/award (A): 24,510 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 94,012 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Sale (S): 2,068 @ $1.96 | EDGAR |
| 2023-02-17 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 483,824 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 5,000 @ $0.65 | EDGAR |
| 2022-04-28 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 2,500 @ $0.68 | EDGAR |
| 2022-04-27 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 5,000 @ $0.69 | EDGAR |
| 2021-10-27 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 2,500 @ $1.66 | EDGAR |
| 2021-05-27 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 200,771 (derivative) @ $0 | EDGAR |
| 2021-05-03 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 2,183 @ $2.28 | EDGAR |
| 2021-03-05 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 2,500 @ $2.50 | EDGAR |
| 2021-02-18 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 88,314 (derivative) @ $0 | EDGAR |
| 2020-12-14 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 2,500 @ $1.99 | EDGAR |
| 2020-12-02 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 2,200 @ $2.14 | EDGAR |
| 2020-08-13 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 4,000 @ $2.58 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1203672 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs